Login to Your Account



Enough to Launch Krystexxa

Savient Prices Offering: $53M on Gout Route to Profitability

By Randy Osborne


Monday, October 12, 2009
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription